Becky Dheri

•Preparing internal pre-conference meeting reports and identifying competitive activities of interest including: posters, platform presentations and company-sponsored symposiums •Attending competitor earnings calls •Reviewing 10Q and 10K reports for competitive companies •Reviewing the competitive landscape for Homozygous Familial Hypercholesterolemia (HoFH)

•Assisted in the strategic development and implementation of publication planning for the Gaucher portfolio •Developed core medical resources for our launch product, including a comprehensive clinical program slide deck used by the current MSL team •Identified publications of interest and provided detailed summaries emphasizing key messages to the Global Medical Affairs team •Performed data collection, analysis, and writing support for the development of an MPS I manuscript •Interacted with key opinion leaders (KOLs) on authorship and clinical expertise

•Assisted with poster and presentation coverage at various conferences and attended competitive symposiums of interest •Worked with the MSL team to develop comprehensive debriefs of conference activities •Presented at multiple MSL/ Global Medical Affairs journal clubs on relevant articles of interest •Attended managed care clinical presentations for our launch product to ensure formulary coverage •Assisted with the development of clinical slide decks to be used by the MSLs in the field •Provided clinical trial data as well as pharmacokinetic/pharmacodynamic information upon request

•Developed a comprehensive understanding of the US payer landscape and became familiar with emerging management trends in the Rare Disease space •Became involved in many of the launch planning streams; aided in the development of value statements, strategic positioning and class management research, net cost strategy workshops, and provided budget impact model feedback •Provided medical input in development of our launch product payer value deck, utilized by the field based Corporate Account Directors (CADs) during their interactions with key accounts •Performed a comprehensive review of the Medicare Part D plan structure to forecast patient out of pocket costs